For citations:
Kushlinskii N.E., Gershtein E.S., Goryatcheva I.O., Morozov A.A., Alferov A.A., Bezhanova S.D., Kazantseva I.A., Bazaev V.V., Matveev V.B. Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations. Cancer Urology. 2019;15(1):15-22. (In Russ.) https://doi.org/10.17650/1726-9776-2019-15-1-15-22
Email this article 